Compared with those without, RA patients with MAFLD had slightly elevated ALT (ULN <ALT <2 ULN: 11.8 vs. 4.5%), a higher GGT (median 27 vs. 20), a higher liver fibrosis score (NFS: median −1.56 vs. −2.19; Forns index: median 5.22 vs. 4.89, respectively), and a higher percentage of advanced fibrosis (NFS: 40.9 vs. 23.1%; Forns index: 32.7 vs. 22.8%, all p < 0.05, Table 2). This evidence concerns the gene GPT and Hepatic fibrosis.